{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:29:06Z","timestamp":1790908146453,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2002,10,1]]},"DOI":"10.1038\/sj.leu.2402638","type":"journal-article","created":{"date-parts":[[2002,10,3]],"date-time":"2002-10-03T10:56:07Z","timestamp":1033642567000},"page":"2078-2083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea"],"prefix":"10.1038","volume":"16","author":[{"given":"P","family":"Bernasconi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Boni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PM","family":"Cavigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Calatroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Brusamolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Passamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pistorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Giardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Caresana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lazzarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,10,2]]},"reference":[{"key":"BF2402638_CR1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood.V93.2.415","volume":"93","author":"SD Nimer","year":"1999","unstructured":"Nimer SD . Essential thrombocythemia: another heterogeneous disease better understood? Blood 1999 93: 415\u2013416","journal-title":"Blood"},{"key":"BF2402638_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","volume":"8","author":"S Cortelazzo","year":"1990","unstructured":"Cortelazzo S, Viero P, Finazzi G, D'Emilio A, Rodighiero F, Barbui T . Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythaemia J Clin Oncol 1990 8: 556\u2013562","journal-title":"J Clin Oncol"},{"key":"BF2402638_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1046\/j.1365-2141.2000.02188.x","volume":"110","author":"G Finazzi","year":"2000","unstructured":"Finazzi G, Ruggeri M, Rodighiero F, Barbui T . Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial Br J Haematol 2000 110: 577\u2013583","journal-title":"Br J Haematol"},{"key":"BF2402638_CR4","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","volume":"332","author":"S Cortelazzo","year":"1995","unstructured":"Cortelazzo S, Finazzi G, Ruggeri M, Vestri O, Galli M, Rodighiero F, Barbui T . Hydroxyurea in the treatment of patients with essential thrombocythaemia at high risk of thrombosis: a prospective randomized trial N Engl J Med 1995 332: 1132\u20131136","journal-title":"N Engl J Med"},{"key":"BF2402638_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000204873","volume":"85","author":"F Cervantes","year":"1991","unstructured":"Cervantes F, Tassies D, Salgado C, Rovira M, Pereira A, Rozman C . Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients Acta Haematol 1991 85: 124\u2013127","journal-title":"Acta Haematol"},{"key":"BF2402638_CR6","first-page":"537","volume":"75","author":"A Chistolini","year":"1990","unstructured":"Chistolini A, Mazzucconi MG, Ferrari A, La Verde G, Ferrazza G, Dragoni F, Vitale A, Arcieri R, Mandelli F . Essential thrombocythemia: a retrospective study on the clinical course of 100 patients Haematologica 1990 75: 537\u2013540","journal-title":"Haematologica"},{"key":"BF2402638_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2141.1986.tb02926.x","volume":"62","author":"JEW Van de Pette","year":"1986","unstructured":"Van de Pette JEW, Prochazka AV, Pearson TC, Singh AK, Dickson ER, Wetherley-Mein G . Primary thrombocythaemia treated with busulfan Br J Haematol 1986 62: 229\u2013237","journal-title":"Br J Haematol"},{"key":"BF2402638_CR8","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood.V91.2.616","volume":"91","author":"Y Sterkers","year":"1998","unstructured":"Sterkers Y, Preudhomme C, La\u00ef J-L, Demory J-L, Caulier M-T, Wattel E, Bordessoule D, Bauters F, Fenaux P . Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion Blood 1998 91: 616\u2013622","journal-title":"Blood"},{"key":"BF2402638_CR9","first-page":"51","volume":"81","author":"C Messora","year":"1996","unstructured":"Messora C, Bensi L, Vanzanelli P, Temperani P, Carotenuto M, Sacchi S . Myelodysplastic transformation in a case of essential thrombocythemia treated with pipobroman Haematologica 1996 81: 51\u201353","journal-title":"Haematologica"},{"key":"BF2402638_CR10","first-page":"29","volume":"34","author":"S Murphy","year":"1997","unstructured":"Murphy S, Peterson P, Iland H, Laszlo J . Experience of the polycythemia vera study group with essential thrombocythaemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment Semin Hematol 1997 34: 29\u201339","journal-title":"Semin Hematol"},{"key":"BF2402638_CR11","volume-title":"An International System for Human Cytogenetic Nomenclature","author":"F Mitelman","year":"1995","unstructured":"Mitelman F (ed). ISCN (1995) An International System for Human Cytogenetic Nomenclature S Karger: Basel 1995"},{"key":"BF2402638_CR12","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/sj.leu.2401827","volume":"14","author":"P Bernasconi","year":"2000","unstructured":"Bernasconi P, Astori C, Cavigliano PM, Boni M, Malcovati L, Calatroni S, Caresana M, Bernasconi C . Cytogenetic and FISH analyses in five patients with hypoplastic bone marrow Leukemia 2000 14: 1322\u20131323","journal-title":"Leukemia"},{"key":"BF2402638_CR13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood.V72.4.1203.1203","volume":"72","author":"G Saglio","year":"1988","unstructured":"Saglio G, Guerrasio A, Tassinari A, Ponzetto A, Zaccaria A, Testoni P, Celso B, Rege-Cambrin G, Serra A, Pegoraro L, Avanzi GC, Attadia V, Falda M, Gavosto F . Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies Blood 1988 72: 1203\u20131208","journal-title":"Blood"},{"key":"BF2402638_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/(SICI)1098-2264(199708)19:4<250::AID-GCC7>3.0.CO;2-W","volume":"19","author":"G Gaidano","year":"1997","unstructured":"Gaidano G, Pastore C, Santini V, Nomdedeu J, Gamberi B, Capello D, Vischia F, Resegotti L, Mazza U, Rossi Ferrini P, Lo Coco F, Saglio F . Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia Genes Chromosomes Cancer 1997 19: 250\u2013255","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2402638_CR15","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1073\/pnas.88.12.5413","volume":"88","author":"G Gaidano","year":"1991","unstructured":"Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R . p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia Proc Natl Acad Sci USA 1991 88: 5413\u20135417","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2402638_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6","volume":"66","author":"P Fenaux","year":"1990","unstructured":"Fenaux P, Simon M, Caulier MT, La JL, Goudemand J, Bauters F . Clinical course of essential thrombocythemia in 147 cases Cancer 1990 66: 549\u2013556","journal-title":"Cancer"},{"key":"BF2402638_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0165-4608(89)90127-1","volume":"43","author":"M Sessarego","year":"1989","unstructured":"Sessarego M, Defferrari R, Dejana AM, Rebuttato AM, Fugazza G, Salvidio E, Ajmar F . Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12 years study Cancer Genet Cytogenet 1989 43: 57\u201365","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2402638_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00282-997-0011-x","volume":"39","author":"E Liozon","year":"1997","unstructured":"Liozon E, Brigadeau C, Trimoreau F, Desangles F, Fermeaux V, Praloran V, Bordessoule D . Is treatment with hydroxyurea leukemogenic in essential thrombocythemia? An analysis of three new cases of leukemic transformation and review of the literature Hematol Cell Ther 1997 39: 11\u201318","journal-title":"Hematol Cell Ther"},{"key":"BF2402638_CR19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.V92.4.1465","volume":"92","author":"T\u2013C Liu","year":"1998","unstructured":"Liu T\u2013C, Suri R . Multiple factors in the transformation of essential thrombocythemia to acute leukemia or myelodysplastic syndrome Blood 1998 92: 1465\u20131466","journal-title":"Blood"},{"key":"BF2402638_CR20","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood.V91.3.1008","volume":"91","author":"V Soenen","year":"1998","unstructured":"Soenen V, Preudhomme C, Roumier C, Daudignon A, La\u00ef JL, Fenaux P . 17p deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ Blood 1998 91: 1008\u20131015","journal-title":"Blood"},{"key":"BF2402638_CR21","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1200\/JCO.2001.19.5.1405","volume":"19","author":"DH Christiansen","year":"2001","unstructured":"Christiansen DH, Andersen MK, Pedersen-Bjergaard J . Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletions or loss of 5q, a complex karyotype, and a poor prognosis J Clin Oncol 2001 19: 1405\u20131413","journal-title":"J Clin Oncol"},{"key":"BF2402638_CR22","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood.V95.6.2138","volume":"95","author":"PD Castro","year":"2000","unstructured":"Castro PD, Liang JC, Nagarajan L . Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms Blood 2000 95: 2138\u20132143","journal-title":"Blood"},{"key":"BF2402638_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/sj.leu.2401298","volume":"13","author":"A Merlat","year":"1999","unstructured":"Merlat A, La\u00ef JL, Sterkers Y, Demory JL, Bauters F, Preudhomme C, Fenaux P . Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases Leukemia 1999 13: 250\u2013257","journal-title":"Leukemia"},{"key":"BF2402638_CR24","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/sj.leu.2402176","volume":"15","author":"J-A Hernadez","year":"2001","unstructured":"Hernadez J-A, Florensa L, Sol\u00e8 F, Bosch M-A, Espinet B . Acute myeloid leukemia with 17p abnormality in untreated essential thrombocythemia Leukemia 2001 15: 1308","journal-title":"Leukemia"},{"key":"BF2402638_CR25","first-page":"1339","volume":"68","author":"E Brusamolino","year":"1984","unstructured":"Brusamolino E, Canevari A, Salvaneschi L, Merante S, Bernasconi C . Efficacy trial of pipobroman in essential thrombocythemia: a study of 24 patients Cancer Treat Rep 1984 68: 1339\u20131342","journal-title":"Cancer Treat Rep"},{"key":"BF2402638_CR26","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1200\/JCO.1984.2.6.558","volume":"2","author":"E Brusamolino","year":"1984","unstructured":"Brusamolino E, Salvaneschi L, Canevari A, Bernasconi C . Efficacy trial of pipobroman in polycythemia vera and incidence of acute leukemia J Clin Oncol 1984 2: 558\u2013561","journal-title":"J Clin Oncol"},{"key":"BF2402638_CR27","first-page":"1011","volume":"85","author":"F Passamonti","year":"2000","unstructured":"Passamonti F, Brusamolino E, Lazzarino M, Barate C, Klersy C, Orlandi E, Canevari A, Castelli G, Merante S, Bernasconi C . Efficacy of pipobroman in the treatment of polycythemia vera: long-term results in 163 patients Haematologica 2000 85: 1011\u20131018","journal-title":"Haematologica"},{"key":"BF2402638_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/gcc.2870040205","volume":"4","author":"RE Kibbelaar","year":"1992","unstructured":"Kibbelaar RE, Mulder JW, van Kamp H, Dreef EJ, Wessels HW, Beverstock GC, Haak HL, Raap AK, Kluin PM . Nonradioactive in situ hybridisation of the translocation t(1;7) in myeloid malignancies Genes Chromosomes Cancer 1992 4: 128\u2013134","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2402638_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/sj.leu.2401594","volume":"14","author":"MK Anderson","year":"2000","unstructured":"Anderson MK, Pedersen-Bjergaard J . Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere Leukemia 2000 14: 105\u2013110","journal-title":"Leukemia"},{"key":"BF2402638_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0165-4608(92)90233-X","volume":"60","author":"B Pedersen","year":"1992","unstructured":"Pedersen B . Survival of patients with t(1;7)(p11;p11). Report of two cases and review of the literature Cancer Genet Cytogenet 1992 60: 53\u201359","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2402638_CR31","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1046\/j.1365-2141.2001.02796.x","volume":"113","author":"A Tefferi","year":"2001","unstructured":"Tefferi A, Mesa RA, Schroeder G, Hanson CA, Li C-Y, Dewald GW . Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia Br J Haematol 2001 113: 763\u2013771","journal-title":"Br J Haematol"},{"key":"BF2402638_CR32","first-page":"445","volume":"38","author":"S Hayashi","year":"1997","unstructured":"Hayashi S, Iwama H, Uchida Y, Kawakubo K, Inatomi Y, Nagasu M, Miyazawa K, Ohyashiki JH, Toyama K . Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7) Rinsho Ketsueki 1997 38: 445\u2013447","journal-title":"Rinsho Ketsueki"},{"key":"BF2402638_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000204260","volume":"91","author":"K Shibata","year":"1994","unstructured":"Shibata K, Shimamoto Y, Suga K, Sano M, Matsuzaki M, Yamaguchi M . Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation \u2013 a brief review of recent literature Acta Haematol 1994 91: 84\u201388","journal-title":"Acta Haematol"},{"key":"BF2402638_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4065\/76.1.22","volume":"76","author":"A Tefferi","year":"2001","unstructured":"Tefferi A, Fonseca R, Pereira DL, Hoagland HC . A long-term retrospective study of young women with essential thrombocythemia Mayo Clin Proc 2001 76: 22\u201328","journal-title":"Mayo Clin Proc"},{"key":"BF2402638_CR35","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V90.9.3370","volume":"90","author":"Y Najean","year":"1997","unstructured":"Najean Y, Rain JD for the French Polycythemia Study Group. Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years Blood 1997 90: 3370\u20133379","journal-title":"Blood"},{"key":"BF2402638_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/10428190009089438","volume":"37","author":"ML Randi","year":"2000","unstructured":"Randi ML, Fabris F, Girolami A . Leukemia and myelodysplasia effect of multiple cytotoxic therapy in essential thrombocythemia Leuk Lymphoma 2000 37: 379\u2013385","journal-title":"Leuk Lymphoma"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402638.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402638","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402638.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:50:22Z","timestamp":1648763422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,1]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10,1]]}},"alternative-id":["BF2402638"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402638","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10,1]]},"assertion":[{"value":"12 April 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}